The section includes updates and press releases from hepCoalition and partner organizations. Includes highlights of upcoming events, actions, and important meetings.
Key strategic and operational shifts required to eliminate chronic viral hepatitis B and C as public health threats by 2030, with priority targets, interventions and innovations. More
Curated list of key international conferences and meetings related to hepatitis C, substance user health, and harm reduction.
World AIDS Day is commemorated each year on 1 December to enhance awareness of the AIDS pandemic. More
The International Viral Hepatitis Elimination Meeting (IVHEM) will take place in Amsterdam, the Netherlands and virtually from 2 to 3 December 2022. More
The section includes updates from partner organizations on related advocacy efforts.
No countries are on track to meet the goals for HBV eradication by 2030 or 2050, and only 11 countries are on track to achieve all absolute or relative targets for HCV elimination. More
Global Fund Partners Pledge Record Level of Support to End Deadly Diseases, Prevent Future Pandemics
The US-hosted pledging conference for the Global Fund to Fight AIDS, Tuberculosis and Malaria raised more than US$14.25 billion so far for the partnership’s work over the next three years. More
Press releases from hepCoalition and partner organizations.
LAT CAB Calls on AbbVie, Licensed Generic Manufacturers of G/P, and the Medicines Patent Pool to Fulfill their Commitment to Make Generic HCV Treatment Widely Available
Four years after MPP and AbbVie came to agreement on a voluntary license authorizing MPP to sublicense G/P to generic manufacturers, generic G/P is not available anywhere. More
Advocates call out Cepheid for canceling commercialization of the portable point-of-care GeneXpert Omni testing instrument and urge the company to reinstate plans to launch Omni. More